These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8261875)

  • 1. Methadone dose and treatment outcome.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Drug Alcohol Depend; 1993 Sep; 33(2):105-17. PubMed ID: 8261875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine versus methadone maintenance for opioid dependence.
    Kosten TR; Schottenfeld R; Ziedonis D; Falcioni J
    J Nerv Ment Dis; 1993 Jun; 181(6):358-64. PubMed ID: 8501457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response effects of methadone in the treatment of opioid dependence.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Ann Intern Med; 1993 Jul; 119(1):23-7. PubMed ID: 8498759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Psychopharmacology (Berl); 1994 Dec; 116(4):401-6. PubMed ID: 7701040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
    Ling W; Wesson DR; Charuvastra C; Klett CJ
    Arch Gen Psychiatry; 1996 May; 53(5):401-7. PubMed ID: 8624183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone maintenance and recovery from opioid dependence.
    Maddux JF; Desmond DP
    Am J Drug Alcohol Abuse; 1992; 18(1):63-74. PubMed ID: 1562007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
    Strain EC; Bigelow GE; Liebson IA; Stitzer ML
    JAMA; 1999 Mar; 281(11):1000-5. PubMed ID: 10086434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.
    Trafton JA; Tracy SW; Oliva EM; Humphreys K
    J Stud Alcohol Drugs; 2007 Mar; 68(2):165-72. PubMed ID: 17286334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after methadone treatment: influence of prior treatment factors and current treatment status.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Drug Alcohol Depend; 1994 Jun; 35(3):223-30. PubMed ID: 7956752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Rittmannsberger H; Ruschak M; Silberbauer C
    Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obtaining follow-up interviews for treatment evaluation.
    Desmond DP; Maddux JF; Johnson TH; Confer BA
    J Subst Abuse Treat; 1995; 12(2):95-102. PubMed ID: 7623396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of buprenorphine and methadone in the treatment of opioid dependence.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Am J Psychiatry; 1994 Jul; 151(7):1025-30. PubMed ID: 8010359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse.
    Schottenfeld RS; Pakes JR; Oliveto A; Ziedonis D; Kosten TR
    Arch Gen Psychiatry; 1997 Aug; 54(8):713-20. PubMed ID: 9283506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug abuse treatment retention and process effects on follow-up outcomes.
    Simpson DD; Joe GW; Rowan-Szal GA
    Drug Alcohol Depend; 1997 Sep; 47(3):227-35. PubMed ID: 9306048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
    Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.